Fluorescence lifetime imaging of cellular-level metabolic heterogeneity in cancer

Melissa C. Skala

2015 European Conference on Lasers and Electro-Optics - European Quantum Electronics Conference
(Optica Publishing Group, 2015),
paper CL_2_3

Fluorescence lifetime imaging of cellular-level metabolic heterogeneity in cancer

Melissa C. Skala

The European Conference on Lasers and Electro-Optics 2015

Munich Germany
21–25 June 2015
ISBN: 978-1-4673-7475-0

From the session
Fluorescence Imaging and Optical Manipulation (CL_2)

Open Access

Get PDF
Email
Share
Get Citation
Copy Citation Text
M. C. Skala, "Fluorescence lifetime imaging of cellular-level metabolic heterogeneity in cancer," in 2015 European Conference on Lasers and Electro-Optics - European Quantum Electronics Conference, (Optica Publishing Group, 2015), paper CL_2_3.

Export Citation
- BibTex
- Endnote (RIS)
- HTML
- Plain Text
Save article

Abstract

Cancer is a heterogeneous disease, and sub-populations of cells can drive drug resistance. Fluorescence lifetime imaging of metabolic co-factors is used to monitor drug response on a cellular level, to optimize clinical treatment decisions.

PDF Article

More Like This

Fluorescence lifetime imaging of cellular heterogeneity in cancer drug response

Melissa C. Skala
AW3H.4 CLEO: Applications and Technology (CLEO:A&T) 2015

Imaging Cellular Metabolic Heterogeneity in Cancer

Melissa C. Skala, Alex J. Walsh, Amy T. Shah, Joseph T. Sharick, Tiffany M. Heaster, Rebecca S. Cook, Carlos L. Arteaga, Melinda E. Sanders, and Ingrid Meszoely
JW4A.1 Cancer Imaging and Therapy (Cancer) 2016

Nonlinear microscopy and population density modeling of tumor cell metabolism

Melissa C. Skala
NT4C.2 Novel Techniques in Microscopy (NTM) 2015

Previous Article Next Article